Regulation of Endothelial Progenitor Cells by Short-Term Exercise
EPC-Ex
1 other identifier
interventional
60
1 country
1
Brief Summary
Endothelial Progenitor Cells (EPCs) are circulating cells released from bone marrow which are important for maintaining cardiovascular health. The prevalence of cardiovascular disease in older adults is associated with reduced circulating EPC numbers. Studies have shown reduced EPC number and function in old vs. young individuals, and endurance exercise training increases EPC number and function in young adults. Oxidative stress adversely affects endothelial cells and preliminary evidence indicates that oxidative stress negatively affects EPC function. Conversely, regular exercise reduces markers of oxidative stress and may enhance EPC function in older adults. The investigators hypothesize that older endurance-trained athletes and matched sedentary individuals will have markedly divergent EPC function and that altering the physical activity levels of both groups will move them to intermediate points between these two extremes. The investigators also propose that the investigators can "mimic" the effect of exercise training on EPC function in cell culture by altering intracellular levels of a key enzyme and a signaling molecule which the investigators have shown to regulate EPC function with respect to exercise training in young individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2010
CompletedFirst Posted
Study publicly available on registry
July 26, 2010
CompletedStudy Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedAugust 22, 2024
August 1, 2024
3.3 years
July 23, 2010
August 20, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Baseline Endothelial progenitor cell number
Day 1
Final Endothelial Progenitor Cell Number
Day 15
Secondary Outcomes (2)
Baseline Endothelial Reactivity
Day 1
Final Endothelial Reactivity
Day 15
Study Arms (2)
Sedentary Older Adults
EXPERIMENTALOlder Endurance Athletes
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- years of age, BMI = 18-35 kg/m2, non-smoking, women must be postmenopausal
You may not qualify if:
- history of cardiovascular/cerebrovascular disease, diabetes, cancer, renal, liver disease, HIV; uncontrolled hyperlipidemia/hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Baltimore VA Medical Centerlead
- University of Maryland, Baltimorecollaborator
- University of Maryland, College Parkcollaborator
Study Sites (1)
University of Maryland, Baltimore & Baltimore VA Medical Center
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven J Prior, Ph.D.
University of Maryland, Baltimore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 23, 2010
First Posted
July 26, 2010
Study Start
July 1, 2011
Primary Completion
November 1, 2014
Study Completion
July 31, 2024
Last Updated
August 22, 2024
Record last verified: 2024-08